SlideShare a Scribd company logo
COVID 19 and Children
• Coronavirus disease 2019 (COVID-19) is an illness caused by severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
• In the United States and throughout the world, fewer cases of COVID-
19 have been reported in children than in adults.
• Whereas children comprise 22% of the US population, approximately
14% of all cases of COVID-19 reported to the Centers for Disease
Control and Prevention (CDC) were among children (as of May 12,
2021).
• Most cases in children are mild, and treatment consists of supportive
care.
INTRODUCTION
INTRODUCTION
• The American Academy of Pediatrics reports children represent 14%
of all confirmed cases in the 49 states reporting by age.
• Over 3.9 million children have tested positive in the United States
since the onset of the pandemic as of May 13, 2021.
• This represents an overall rate of 5,187 cases per 100,000 children.
During the 2-week period of April 29 to May 13, 2021, there was a 3%
increase in the cumulated number of children who tested positive,
representing 120,982 new cases.
• Children were 1.3-3.1% of total reported hospitalizations, and from
0.1-1.9% of all child COVID-19 cases resulted in hospitalization
ETIOLOGY
Transmission
• Severe acute respiratory syndrome coronavirus 2 (SARS CoV-2) is a highly
infectious virus
• The main routes of transmission are respiratory droplets and contact with
respiratory secretions and saliva.
• Aerosol particles may be another possible mode of transmission.
• SARS CoV-2 can remain viable on various surfaces for hours to days,
although transmission is much more common through respiratory droplets
than through fomites.
• Fecal shedding has been detected for several weeks after diagnosis, which
has led to concerns about fecal-oral transmission of the virus.
ETIOLOGY
Mother-to-child transmission
• Based on limited data, no confirmed cases of vertical mother-to-fetus
intrauterine transmission of the virus have been reported thus far.
• A multicenter study involving 16 Spanish hospitals reported outcomes of 242
pregnant women diagnosed with COVID-19 during their third trimester from
March 13 to May 31, 2020.
• The women and their 248 newborns were monitored until the infant was 1
month old.
• COVID-19–positive mothers who were hospitalized had a higher risk of ending
their pregnancy via cesarean section (P = .027).
• Newborns whose mothers had been admitted owing to their COVID-19 infection
had a higher risk of premature delivery (P = .006).
• No infants died, and no vertical or horizontal transmission was detected.
• The percentage of infants exclusively breastfed at discharge was 41.7% and was
40.4% at 1 month.
• To date, SARS CoV-2 has not been detected in breast milk.
• A study by Chambers et al found human milk is unlikely to transmit
SARS CoV-2 from infected mothers to infants.
• The study included 64 milk samples provided by 18 mothers infected
with COVID-19.
• Samples were collected before and after COVID-19 diagnosis.
• No replication-competent virus was detectable in any of their milk
samples compared with samples of human milk that were
experimentally infected with SARS CoV-2.
Family clustering
• Family clustering appears to play a major role in disease transmission.
• In one study, just over half of children with coronavirus disease 2019
(COVID-19) in China had evidence of transmission through family
clustering.
• Most of the children in the US data also had exposure to a patient
with COVID-19 in the household or community.
Community transmission
• Cruz and Zeichner suggested that children have a role in community-
based viral transmission.
• They noted that children are more likely than adults to have upper
respiratory tract involvement, including nasopharyngeal carriage.
• They may also have prolonged respiratory and fecal shedding.
Epidemiology
• Fewer cases of coronavirus disease 2019 (COVID-19) have been diagnosed in
children than in adults
• The majority of the pediatric cases have been mild. Whereas children comprise
22% of the US population, approximately 14% of all cases of COVID-19 reported
to the Centers for Disease Control and Prevention (CDC) were among children (as
of May 12, 2021).
• The number and rate of cases in children in the US have been steadily
increasing.[1]
• The true incidence of SARS-CoV-2 infection in children is not known, owing to the
lack of widespread testing and the prioritization of testing for adults and those
with severe illness.
• Hospitalization rates in children are significantly lower than hospitalization rates
in adults with COVID-19, which suggests that children may have less severe illness
from COVID-19 compared with adults.[1]
Epidemiology
• The American Academy of Pediatrics reports children represent 14%
of all confirmed cases in the 49 states reporting by age.
• Over 3.9 million children have tested positive in the United States
since the onset of the pandemic as of May 13, 2021.
• This represents an overall rate of 5,187 cases per 100,000 children.
• During the 2-week period of April 29 to May 13, 2021, there was a
3% increase in the cumulated number of children who tested positive,
representing 120,982 new cases.
• Race-, sex-, and age-related demographics
• No racial predilection has been observed in children
INCUBATION PERIOD
• The typical incubation period of coronavirus disease 2019 (COVID-19)
ranges from 1 to 14 days, with an average of 3-7 days.
• However, longer incubation periods (up to 24 days) have been
reported.
• In most of the early pediatric cases reported from China, the patient
had a close contact with COVID-19 or was part of a family cluster of
cases.
Physical examination
• Lu et al evaluated 171 children with confirmed severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) infection who were treated at the
Wuhan Children’s Hospital in China.
• They reported that the most common signs and symptoms were cough
(48.5% of patients), pharyngeal erythema (46.2%), and fever (41.5%).
Other signs and symptoms included the following:
Diarrhea (8.8% of patients)
Fatigue (7.6%)
Rhinorrhea (7.6%)
Vomiting (6.4%)
Nasal congestion (5.3%)
About 29% of patients had tachypnea on admission
42% had tachycardia.
 Slightly more than 2% of children had an oxygen saturation of < 92% during their
hospitalization.
Rash has been reported in patients with COVID-19.
The following conditions indicate a greater likelihood of severe
disease:
• Dyspnea: Respiration rate of >50 breaths/min in children aged 2-12 months; >40
breaths/min in children aged 1-5 years; >30 breaths/min in patients older than 5
years old
• Persistent high fever for 3-5 days.
• Poor mental response, lethargy, disturbance of consciousness, and other changes
of consciousness.
• Abnormally increased levels of enzymes, such as myocardial and liver enzymes
and lactate dehydrogenase.
• Unexplained metabolic acidosis.
• Chest imaging findings indicating bilateral or multi-lobe infiltration, pleural
effusion, or rapid progression of conditions during a very brief period.
• Age younger than 3 months.
• Extrapulmonary complications.
• Coinfection with other viruses or bacteria.
Thank You

More Related Content

What's hot

PAEDIATRICS HIV
PAEDIATRICS HIVPAEDIATRICS HIV
PAEDIATRICS HIV
hanisahwarrior
 
Coronavirus disease 2019(covid 19)
Coronavirus disease 2019(covid 19)Coronavirus disease 2019(covid 19)
Coronavirus disease 2019(covid 19)
Denis Katatwire
 
COVID-19 / SARS CoV2 disease
COVID-19 / SARS CoV2 diseaseCOVID-19 / SARS CoV2 disease
COVID-19 / SARS CoV2 disease
Shiva Kandel
 
Parvovirus b19 infection
Parvovirus b19 infectionParvovirus b19 infection
Parvovirus b19 infection
Dr. Saad Saleh Al Ani
 
Approach to congenital cmv infection in newborn
Approach to congenital cmv infection in newbornApproach to congenital cmv infection in newborn
Approach to congenital cmv infection in newborn
Jigar Patel
 
Cornovirus Microbiology and Management
Cornovirus Microbiology and Management Cornovirus Microbiology and Management
Cornovirus Microbiology and Management
DrShrey Bhatia
 
COVID-19 Variants. by Dr.T.V.Rao MD
COVID-19 Variants. by Dr.T.V.Rao MDCOVID-19 Variants. by Dr.T.V.Rao MD
COVID-19 Variants. by Dr.T.V.Rao MD
Society for Microbiology and Infection care
 
Covid 19 (corona virus)
Covid 19 (corona virus)Covid 19 (corona virus)
Covid 19 (corona virus)
Amar joseph
 
Pneumonia in children by dr. sundar karki
Pneumonia in children  by dr. sundar karkiPneumonia in children  by dr. sundar karki
Pneumonia in children by dr. sundar karki
Dr. Sundar Karki
 
COVID-19
COVID-19COVID-19
Corona Virus (SARS-Cov-2) and covid 19 disease
Corona Virus (SARS-Cov-2) and covid 19 diseaseCorona Virus (SARS-Cov-2) and covid 19 disease
Corona Virus (SARS-Cov-2) and covid 19 disease
OKELLO ISAAC OPIO
 
Pneumonia in children
Pneumonia in children Pneumonia in children
Pneumonia in children
Azad Haleem
 
COVID-19 immunology, MIS-C, and allergic diseases
COVID-19 immunology, MIS-C, and allergic diseases COVID-19 immunology, MIS-C, and allergic diseases
COVID-19 immunology, MIS-C, and allergic diseases
Chulalongkorn Allergy and Clinical Immunology Research Group
 
Chickenpox
ChickenpoxChickenpox
Chickenpox
Rahul Ratnakumar
 
Covid vaccine
Covid vaccineCovid vaccine
Covid vaccine
MonikaSkarbek
 
Congenital cytomegalovirus infection
Congenital cytomegalovirus infectionCongenital cytomegalovirus infection
Congenital cytomegalovirus infection
Dr. Maimuna Sayeed
 
Pneumonia in children
Pneumonia in childrenPneumonia in children
Pneumonia in children
DR MUKESH SAH
 
Multisystem inflammatory syndrome in children (MIS-C) in COVID19
Multisystem inflammatory syndrome in children (MIS-C) in COVID19Multisystem inflammatory syndrome in children (MIS-C) in COVID19
Multisystem inflammatory syndrome in children (MIS-C) in COVID19
صقري بن شاهين
 
Respiratory distress in newborn
Respiratory distress in newborn Respiratory distress in newborn
Respiratory distress in newborn
Aftab Siddiqui
 
Respiratory failure in children
Respiratory failure in childrenRespiratory failure in children
Respiratory failure in children
Mohammad Rezaei
 

What's hot (20)

PAEDIATRICS HIV
PAEDIATRICS HIVPAEDIATRICS HIV
PAEDIATRICS HIV
 
Coronavirus disease 2019(covid 19)
Coronavirus disease 2019(covid 19)Coronavirus disease 2019(covid 19)
Coronavirus disease 2019(covid 19)
 
COVID-19 / SARS CoV2 disease
COVID-19 / SARS CoV2 diseaseCOVID-19 / SARS CoV2 disease
COVID-19 / SARS CoV2 disease
 
Parvovirus b19 infection
Parvovirus b19 infectionParvovirus b19 infection
Parvovirus b19 infection
 
Approach to congenital cmv infection in newborn
Approach to congenital cmv infection in newbornApproach to congenital cmv infection in newborn
Approach to congenital cmv infection in newborn
 
Cornovirus Microbiology and Management
Cornovirus Microbiology and Management Cornovirus Microbiology and Management
Cornovirus Microbiology and Management
 
COVID-19 Variants. by Dr.T.V.Rao MD
COVID-19 Variants. by Dr.T.V.Rao MDCOVID-19 Variants. by Dr.T.V.Rao MD
COVID-19 Variants. by Dr.T.V.Rao MD
 
Covid 19 (corona virus)
Covid 19 (corona virus)Covid 19 (corona virus)
Covid 19 (corona virus)
 
Pneumonia in children by dr. sundar karki
Pneumonia in children  by dr. sundar karkiPneumonia in children  by dr. sundar karki
Pneumonia in children by dr. sundar karki
 
COVID-19
COVID-19COVID-19
COVID-19
 
Corona Virus (SARS-Cov-2) and covid 19 disease
Corona Virus (SARS-Cov-2) and covid 19 diseaseCorona Virus (SARS-Cov-2) and covid 19 disease
Corona Virus (SARS-Cov-2) and covid 19 disease
 
Pneumonia in children
Pneumonia in children Pneumonia in children
Pneumonia in children
 
COVID-19 immunology, MIS-C, and allergic diseases
COVID-19 immunology, MIS-C, and allergic diseases COVID-19 immunology, MIS-C, and allergic diseases
COVID-19 immunology, MIS-C, and allergic diseases
 
Chickenpox
ChickenpoxChickenpox
Chickenpox
 
Covid vaccine
Covid vaccineCovid vaccine
Covid vaccine
 
Congenital cytomegalovirus infection
Congenital cytomegalovirus infectionCongenital cytomegalovirus infection
Congenital cytomegalovirus infection
 
Pneumonia in children
Pneumonia in childrenPneumonia in children
Pneumonia in children
 
Multisystem inflammatory syndrome in children (MIS-C) in COVID19
Multisystem inflammatory syndrome in children (MIS-C) in COVID19Multisystem inflammatory syndrome in children (MIS-C) in COVID19
Multisystem inflammatory syndrome in children (MIS-C) in COVID19
 
Respiratory distress in newborn
Respiratory distress in newborn Respiratory distress in newborn
Respiratory distress in newborn
 
Respiratory failure in children
Respiratory failure in childrenRespiratory failure in children
Respiratory failure in children
 

Similar to Pediatric and covid 19

Covid 19 in children consensus statement
Covid 19 in children consensus statementCovid 19 in children consensus statement
Covid 19 in children consensus statement
gisa_legal
 
Clinical chacateristics of novel coronavirua in newborns, infants, and children
Clinical chacateristics of novel coronavirua in newborns, infants, and childrenClinical chacateristics of novel coronavirua in newborns, infants, and children
Clinical chacateristics of novel coronavirua in newborns, infants, and children
gisa_legal
 
Chen2020 article diagnosis_andtreatmentrecommend
Chen2020 article diagnosis_andtreatmentrecommendChen2020 article diagnosis_andtreatmentrecommend
Chen2020 article diagnosis_andtreatmentrecommend
gisa_legal
 
Covid19 peds case summaries pediatrics peds.2020 0702
Covid19 peds case summaries pediatrics peds.2020 0702Covid19 peds case summaries pediatrics peds.2020 0702
Covid19 peds case summaries pediatrics peds.2020 0702
gisa_legal
 
Covid19 peds case summaries pediatrics peds.2020 0702
Covid19 peds case summaries pediatrics peds.2020 0702Covid19 peds case summaries pediatrics peds.2020 0702
Covid19 peds case summaries pediatrics peds.2020 0702
gisa_legal
 
Peds.2020 0834
Peds.2020 0834Peds.2020 0834
Peds.2020 0834
gisa_legal
 
Peds.2020 07021
Peds.2020 07021Peds.2020 07021
Peds.2020 07021
gisa_legal
 
Peds.2020 07020
Peds.2020 07020Peds.2020 07020
Peds.2020 07020
gisa_legal
 
06.12.20 | Coronavirus Disease 2019 in Children
06.12.20 | Coronavirus Disease 2019 in Children06.12.20 | Coronavirus Disease 2019 in Children
06.12.20 | Coronavirus Disease 2019 in Children
UC San Diego AntiViral Research Center
 
Clinical features od severe pediatric patients with coronavirus disease 2019 ...
Clinical features od severe pediatric patients with coronavirus disease 2019 ...Clinical features od severe pediatric patients with coronavirus disease 2019 ...
Clinical features od severe pediatric patients with coronavirus disease 2019 ...
Valentina Corona
 
The Latest on COVID19 & The Promise of The COVID19 Vaccine: A Pediatrician's...
The Latest on COVID19 & The Promise of The COVID19 Vaccine:  A Pediatrician's...The Latest on COVID19 & The Promise of The COVID19 Vaccine:  A Pediatrician's...
The Latest on COVID19 & The Promise of The COVID19 Vaccine: A Pediatrician's...
Katherine Noble
 
Covid19 and pregnancy
Covid19 and pregnancyCovid19 and pregnancy
Covid19 and pregnancy
Dr Shivani Sachdev Gour
 
Covid19 and pregnancy
Covid19 and pregnancyCovid19 and pregnancy
Covid19 and pregnancy
Shivani Sachdev
 
Covid vaccination during pregnancy
Covid vaccination during pregnancyCovid vaccination during pregnancy
Covid vaccination during pregnancy
AnushikaKedawat
 
CLINICAL FEATURES, DIFFERENCES IN COVID FIRST, SECOND, THIRD WAVES- A DATA BA...
CLINICAL FEATURES, DIFFERENCES IN COVID FIRST, SECOND, THIRD WAVES- A DATA BA...CLINICAL FEATURES, DIFFERENCES IN COVID FIRST, SECOND, THIRD WAVES- A DATA BA...
CLINICAL FEATURES, DIFFERENCES IN COVID FIRST, SECOND, THIRD WAVES- A DATA BA...
DrHeena tiwari
 
Sepsis neonatal manejo antimicrobiano ideal
Sepsis neonatal manejo antimicrobiano idealSepsis neonatal manejo antimicrobiano ideal
Sepsis neonatal manejo antimicrobiano ideal
Aracely Michelle Hernandez
 
PHA Covid vaccination training slides Programme for childbearing women FINAL ...
PHA Covid vaccination training slides Programme for childbearing women FINAL ...PHA Covid vaccination training slides Programme for childbearing women FINAL ...
PHA Covid vaccination training slides Programme for childbearing women FINAL ...
IslamSaeed19
 
Dr hatem el bitar covid19 presention for pediatric
Dr hatem el bitar covid19 presention for pediatricDr hatem el bitar covid19 presention for pediatric
Dr hatem el bitar covid19 presention for pediatric
د حاتم البيطار
 
Covid 19 Infection in Children Revised
Covid 19 Infection in Children RevisedCovid 19 Infection in Children Revised
Covid 19 Infection in Children Revised
Vinit Warthe
 
2854-Article Text-12962-1-18-20230410.doc
2854-Article Text-12962-1-18-20230410.doc2854-Article Text-12962-1-18-20230410.doc
2854-Article Text-12962-1-18-20230410.doc
RizalMarubobSilalahi
 

Similar to Pediatric and covid 19 (20)

Covid 19 in children consensus statement
Covid 19 in children consensus statementCovid 19 in children consensus statement
Covid 19 in children consensus statement
 
Clinical chacateristics of novel coronavirua in newborns, infants, and children
Clinical chacateristics of novel coronavirua in newborns, infants, and childrenClinical chacateristics of novel coronavirua in newborns, infants, and children
Clinical chacateristics of novel coronavirua in newborns, infants, and children
 
Chen2020 article diagnosis_andtreatmentrecommend
Chen2020 article diagnosis_andtreatmentrecommendChen2020 article diagnosis_andtreatmentrecommend
Chen2020 article diagnosis_andtreatmentrecommend
 
Covid19 peds case summaries pediatrics peds.2020 0702
Covid19 peds case summaries pediatrics peds.2020 0702Covid19 peds case summaries pediatrics peds.2020 0702
Covid19 peds case summaries pediatrics peds.2020 0702
 
Covid19 peds case summaries pediatrics peds.2020 0702
Covid19 peds case summaries pediatrics peds.2020 0702Covid19 peds case summaries pediatrics peds.2020 0702
Covid19 peds case summaries pediatrics peds.2020 0702
 
Peds.2020 0834
Peds.2020 0834Peds.2020 0834
Peds.2020 0834
 
Peds.2020 07021
Peds.2020 07021Peds.2020 07021
Peds.2020 07021
 
Peds.2020 07020
Peds.2020 07020Peds.2020 07020
Peds.2020 07020
 
06.12.20 | Coronavirus Disease 2019 in Children
06.12.20 | Coronavirus Disease 2019 in Children06.12.20 | Coronavirus Disease 2019 in Children
06.12.20 | Coronavirus Disease 2019 in Children
 
Clinical features od severe pediatric patients with coronavirus disease 2019 ...
Clinical features od severe pediatric patients with coronavirus disease 2019 ...Clinical features od severe pediatric patients with coronavirus disease 2019 ...
Clinical features od severe pediatric patients with coronavirus disease 2019 ...
 
The Latest on COVID19 & The Promise of The COVID19 Vaccine: A Pediatrician's...
The Latest on COVID19 & The Promise of The COVID19 Vaccine:  A Pediatrician's...The Latest on COVID19 & The Promise of The COVID19 Vaccine:  A Pediatrician's...
The Latest on COVID19 & The Promise of The COVID19 Vaccine: A Pediatrician's...
 
Covid19 and pregnancy
Covid19 and pregnancyCovid19 and pregnancy
Covid19 and pregnancy
 
Covid19 and pregnancy
Covid19 and pregnancyCovid19 and pregnancy
Covid19 and pregnancy
 
Covid vaccination during pregnancy
Covid vaccination during pregnancyCovid vaccination during pregnancy
Covid vaccination during pregnancy
 
CLINICAL FEATURES, DIFFERENCES IN COVID FIRST, SECOND, THIRD WAVES- A DATA BA...
CLINICAL FEATURES, DIFFERENCES IN COVID FIRST, SECOND, THIRD WAVES- A DATA BA...CLINICAL FEATURES, DIFFERENCES IN COVID FIRST, SECOND, THIRD WAVES- A DATA BA...
CLINICAL FEATURES, DIFFERENCES IN COVID FIRST, SECOND, THIRD WAVES- A DATA BA...
 
Sepsis neonatal manejo antimicrobiano ideal
Sepsis neonatal manejo antimicrobiano idealSepsis neonatal manejo antimicrobiano ideal
Sepsis neonatal manejo antimicrobiano ideal
 
PHA Covid vaccination training slides Programme for childbearing women FINAL ...
PHA Covid vaccination training slides Programme for childbearing women FINAL ...PHA Covid vaccination training slides Programme for childbearing women FINAL ...
PHA Covid vaccination training slides Programme for childbearing women FINAL ...
 
Dr hatem el bitar covid19 presention for pediatric
Dr hatem el bitar covid19 presention for pediatricDr hatem el bitar covid19 presention for pediatric
Dr hatem el bitar covid19 presention for pediatric
 
Covid 19 Infection in Children Revised
Covid 19 Infection in Children RevisedCovid 19 Infection in Children Revised
Covid 19 Infection in Children Revised
 
2854-Article Text-12962-1-18-20230410.doc
2854-Article Text-12962-1-18-20230410.doc2854-Article Text-12962-1-18-20230410.doc
2854-Article Text-12962-1-18-20230410.doc
 

Recently uploaded

263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,
sisternakatoto
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
MedicoseAcademics
 
Pictures of Superficial & Deep Fascia.ppt.pdf
Pictures of Superficial & Deep Fascia.ppt.pdfPictures of Superficial & Deep Fascia.ppt.pdf
Pictures of Superficial & Deep Fascia.ppt.pdf
Dr. Rabia Inam Gandapore
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Savita Shen $i11
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
MedicoseAcademics
 
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptxPharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
aljamhori teaching hospital
 
Pharma Pcd Franchise in Jharkhand - Yodley Lifesciences
Pharma Pcd Franchise in Jharkhand - Yodley LifesciencesPharma Pcd Franchise in Jharkhand - Yodley Lifesciences
Pharma Pcd Franchise in Jharkhand - Yodley Lifesciences
Yodley Lifesciences
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
GL Anaacs
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
SumeraAhmad5
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
LanceCatedral
 
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfMANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
Jim Jacob Roy
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Saeid Safari
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
vimalpl1234
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
Anurag Sharma
 
New Drug Discovery and Development .....
New Drug Discovery and Development .....New Drug Discovery and Development .....
New Drug Discovery and Development .....
NEHA GUPTA
 
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
Savita Shen $i11
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
MedicoseAcademics
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
Shweta
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
FFragrant
 

Recently uploaded (20)

263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
 
Pictures of Superficial & Deep Fascia.ppt.pdf
Pictures of Superficial & Deep Fascia.ppt.pdfPictures of Superficial & Deep Fascia.ppt.pdf
Pictures of Superficial & Deep Fascia.ppt.pdf
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
 
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptxPharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
 
Pharma Pcd Franchise in Jharkhand - Yodley Lifesciences
Pharma Pcd Franchise in Jharkhand - Yodley LifesciencesPharma Pcd Franchise in Jharkhand - Yodley Lifesciences
Pharma Pcd Franchise in Jharkhand - Yodley Lifesciences
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
 
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfMANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
 
New Drug Discovery and Development .....
New Drug Discovery and Development .....New Drug Discovery and Development .....
New Drug Discovery and Development .....
 
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
 

Pediatric and covid 19

  • 1. COVID 19 and Children
  • 2. • Coronavirus disease 2019 (COVID-19) is an illness caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). • In the United States and throughout the world, fewer cases of COVID- 19 have been reported in children than in adults. • Whereas children comprise 22% of the US population, approximately 14% of all cases of COVID-19 reported to the Centers for Disease Control and Prevention (CDC) were among children (as of May 12, 2021). • Most cases in children are mild, and treatment consists of supportive care. INTRODUCTION
  • 3. INTRODUCTION • The American Academy of Pediatrics reports children represent 14% of all confirmed cases in the 49 states reporting by age. • Over 3.9 million children have tested positive in the United States since the onset of the pandemic as of May 13, 2021. • This represents an overall rate of 5,187 cases per 100,000 children. During the 2-week period of April 29 to May 13, 2021, there was a 3% increase in the cumulated number of children who tested positive, representing 120,982 new cases. • Children were 1.3-3.1% of total reported hospitalizations, and from 0.1-1.9% of all child COVID-19 cases resulted in hospitalization
  • 4. ETIOLOGY Transmission • Severe acute respiratory syndrome coronavirus 2 (SARS CoV-2) is a highly infectious virus • The main routes of transmission are respiratory droplets and contact with respiratory secretions and saliva. • Aerosol particles may be another possible mode of transmission. • SARS CoV-2 can remain viable on various surfaces for hours to days, although transmission is much more common through respiratory droplets than through fomites. • Fecal shedding has been detected for several weeks after diagnosis, which has led to concerns about fecal-oral transmission of the virus.
  • 5. ETIOLOGY Mother-to-child transmission • Based on limited data, no confirmed cases of vertical mother-to-fetus intrauterine transmission of the virus have been reported thus far. • A multicenter study involving 16 Spanish hospitals reported outcomes of 242 pregnant women diagnosed with COVID-19 during their third trimester from March 13 to May 31, 2020. • The women and their 248 newborns were monitored until the infant was 1 month old. • COVID-19–positive mothers who were hospitalized had a higher risk of ending their pregnancy via cesarean section (P = .027). • Newborns whose mothers had been admitted owing to their COVID-19 infection had a higher risk of premature delivery (P = .006). • No infants died, and no vertical or horizontal transmission was detected. • The percentage of infants exclusively breastfed at discharge was 41.7% and was 40.4% at 1 month.
  • 6. • To date, SARS CoV-2 has not been detected in breast milk. • A study by Chambers et al found human milk is unlikely to transmit SARS CoV-2 from infected mothers to infants. • The study included 64 milk samples provided by 18 mothers infected with COVID-19. • Samples were collected before and after COVID-19 diagnosis. • No replication-competent virus was detectable in any of their milk samples compared with samples of human milk that were experimentally infected with SARS CoV-2.
  • 7. Family clustering • Family clustering appears to play a major role in disease transmission. • In one study, just over half of children with coronavirus disease 2019 (COVID-19) in China had evidence of transmission through family clustering. • Most of the children in the US data also had exposure to a patient with COVID-19 in the household or community. Community transmission • Cruz and Zeichner suggested that children have a role in community- based viral transmission. • They noted that children are more likely than adults to have upper respiratory tract involvement, including nasopharyngeal carriage. • They may also have prolonged respiratory and fecal shedding.
  • 8. Epidemiology • Fewer cases of coronavirus disease 2019 (COVID-19) have been diagnosed in children than in adults • The majority of the pediatric cases have been mild. Whereas children comprise 22% of the US population, approximately 14% of all cases of COVID-19 reported to the Centers for Disease Control and Prevention (CDC) were among children (as of May 12, 2021). • The number and rate of cases in children in the US have been steadily increasing.[1] • The true incidence of SARS-CoV-2 infection in children is not known, owing to the lack of widespread testing and the prioritization of testing for adults and those with severe illness. • Hospitalization rates in children are significantly lower than hospitalization rates in adults with COVID-19, which suggests that children may have less severe illness from COVID-19 compared with adults.[1]
  • 9. Epidemiology • The American Academy of Pediatrics reports children represent 14% of all confirmed cases in the 49 states reporting by age. • Over 3.9 million children have tested positive in the United States since the onset of the pandemic as of May 13, 2021. • This represents an overall rate of 5,187 cases per 100,000 children. • During the 2-week period of April 29 to May 13, 2021, there was a 3% increase in the cumulated number of children who tested positive, representing 120,982 new cases. • Race-, sex-, and age-related demographics • No racial predilection has been observed in children
  • 10. INCUBATION PERIOD • The typical incubation period of coronavirus disease 2019 (COVID-19) ranges from 1 to 14 days, with an average of 3-7 days. • However, longer incubation periods (up to 24 days) have been reported. • In most of the early pediatric cases reported from China, the patient had a close contact with COVID-19 or was part of a family cluster of cases.
  • 11. Physical examination • Lu et al evaluated 171 children with confirmed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection who were treated at the Wuhan Children’s Hospital in China. • They reported that the most common signs and symptoms were cough (48.5% of patients), pharyngeal erythema (46.2%), and fever (41.5%). Other signs and symptoms included the following: Diarrhea (8.8% of patients) Fatigue (7.6%) Rhinorrhea (7.6%) Vomiting (6.4%) Nasal congestion (5.3%) About 29% of patients had tachypnea on admission 42% had tachycardia.  Slightly more than 2% of children had an oxygen saturation of < 92% during their hospitalization. Rash has been reported in patients with COVID-19.
  • 12. The following conditions indicate a greater likelihood of severe disease: • Dyspnea: Respiration rate of >50 breaths/min in children aged 2-12 months; >40 breaths/min in children aged 1-5 years; >30 breaths/min in patients older than 5 years old • Persistent high fever for 3-5 days. • Poor mental response, lethargy, disturbance of consciousness, and other changes of consciousness. • Abnormally increased levels of enzymes, such as myocardial and liver enzymes and lactate dehydrogenase. • Unexplained metabolic acidosis. • Chest imaging findings indicating bilateral or multi-lobe infiltration, pleural effusion, or rapid progression of conditions during a very brief period. • Age younger than 3 months. • Extrapulmonary complications. • Coinfection with other viruses or bacteria.